Biologic Dressings in Chronic Wounds: Mechanisms and Applications

Understanding Chronic Wounds

Chronic wounds are those that fail to progress through the normal phases of healing within an expected timeframe, often defined as persisting for more than four to six weeks. These wounds are typically associated with underlying conditions such as diabetes, vascular disease, or prolonged pressure. Impaired angiogenesis, persistent inflammation, and disrupted extracellular matrix remodeling all contribute to delayed wound closure.

What Are Biologic Dressings?

Biologic dressings are wound care products derived from human or animal tissue, designed to support the wound environment and aid in tissue regeneration. They differ from synthetic or traditional dressings by preserving natural structures such as the extracellular matrix (ECM), growth factors, and signaling proteins.

Common types include:

  • Amniotic membrane grafts
  • Acellular dermal matrices
  • Xenografts (e.g., porcine small intestinal submucosa)

Mechanisms of Action in Chronic Wounds

Biologic dressings contribute to wound management through several observed mechanisms:

Structural Support

The preserved ECM provides a scaffold for cellular migration, attachment, and organization. This is critical in wounds where native tissue architecture is degraded.

Modulation of Inflammation

Some biologic materials retain anti-inflammatory cytokines and regulatory proteins. These elements may help modulate the chronic inflammatory state and support a transition into the proliferative phase of healing.

Growth Factor Reservoir

Many grafts preserve endogenous growth factors such as VEGF, EGF, and TGF-β. These contribute to cellular proliferation, angiogenesis, and matrix remodeling. These processes are often impaired in chronic wounds.

Protection and Barrier Function

Biologic dressings also act as physical barriers, protecting the wound bed from mechanical trauma and microbial invasion while maintaining a moist healing environment.

Clinical Applications

Biologic dressings are used across a range of chronic wound types, including:

  • Diabetic foot ulcers
  • Venous leg ulcers
  • Pressure injuries
  • Non-healing surgical wounds

Frequency of application varies by product type and wound status. Some are applied weekly, while others may remain in place for several days.

Considerations in Product Selection

When evaluating biologic dressings, providers should assess:

  • Source and type of tissue
  • Processing methods (e.g., decellularization, sterilization)
  • Preservation of bioactive components
  • Handling characteristics and shelf life

These factors influence graft performance and suitability for specific wound types or care settings.

Summary

For reference, see the review article on biologic dressings in chronic wound care and a discussion on growth factor activity in chronic wounds.

Biologic dressings in chronic wounds offer structural and biochemical support that can help address the impaired healing environment. By preserving native tissue elements, these products can complement standard wound care strategies and are commonly used in specialized wound care protocols. Understanding their mechanisms and characteristics helps providers make informed, case-appropriate decisions.

If you’re interested in offering amniotic grafts in your clinical practice, contact GWS Biologics to learn more about becoming a wound care provider.

Become a Provider